59 results about "WATER SOLUBLE BASE" patented technology

Disclosed is an ointment using the salts or esters of clindamycinum and metronidazole as the active constituents, the constituents of the ointment include (by weight percent): clindamycinum or its medicinal salts or its esters 0.25-5%, metronidazole 0.2-4%, oleaginous base 10-40%, water soluble base 5-50%, and balancing water, wherein the oleaginous base is selected from stearinic acid, glyceryl monostearate, paraffin wax, fluid wax, Vaseline, lanoline, cetyl alcohol, stearyl alcohol, Span series, bee wax, animal or vegetable fat, the water soluble base is selected from glycerin, propylene glycol, sorbitol, polyethylene glycol series, Tween series, sodium dodecylsulfate, dimethyl sulfoxide, triethanolamine, and ethanol.

The invention relates to a agricultural chemicals branch of technology, specifically to an agriculture chemicals effervescence composition and a preparation method thereof.The invention discloses an agricultural chemicals effervescence composition comprising effervescence components, active compounds of agricultural chemicals, and the invention is characterized in that, taking the total weight as the basic reference, the agricultural chemicals effervescence composition also comprises the following components that water soluble base with a percentage by weight of 5-45% and water-soluble high molecular polymer with percentage by weight of 3-30% which form a united vector, and the active ingredients of agricultural chemicals are coated by the carrier to form a solid highly dispersed system.Every type of matters in the agricultural chemicals effervescence composition of the present invention has a better water-soluble performance, active compounds of agricultural chemicals can be highly dispersed into particles with a size of 0.001-0.1micrometre, the particle size of the active compounds of agricultural chemicals is much smaller than that of water-dispersion granulas, water dispersible powder and the like, the composition does not include any water-insoluble matters such as waterproofing agents, thinning agent and the like that are used by conventional effervescing agents, and once in water, the obtained effervescence composition is disintegrated instantly and rapidly and can be diffuse easily.Therefore, suspending particulate matters will never appear in the obtained solution, and if the prescription is reasonable, the solution will be clear and transparent; therefore, the composition can not only be used for expelling agriculture disease, but also be extensively used in the filed of expelling sanitation disease.

This invention relates to a stable aqueous wax dispersion comprisingA) from 5 to 65% by weight of micronized wax, the wax comprising an amide wax, polyethylene wax, modified polyethylene wax, polyethylene / amide wax, polyethylene / polytetrafluroethylene (PTFE) wax, polypropylene wax, modified polypropylene wax, polyethylene / polypropylene wax,polytetrafluroethylene (PTFE) wax or copolymers thereof or any mixture thereof having a mean particle size of from 1 to 100 μm and an acid number of less then 10 mg of KOH / g of wax andB) 0.5 to 20% by weight of a thickening / dispersing agent, comprising of a alkali swellable acrylic polymers (ASE) or a hydrophobically modified alkali swellable emulsion (HASE) or a hydrophobically modified ethoxylated urethane (HEUR) or a polymer containing both a high molecular weight acrylic copolymer moiety and a hydrophobically modified ethoxylated urethane as a thickening / dispersing agent or mixtures thereofC) 0 to 5% by weight of a water soluble base as a neutralizing agentD) 0 to 5% by weight of a surface active / dispersant agentE) 0 to 40% by weight of a polymeric binder or polymeric bindersF) 0 to 5% by weight smectic clay thickening agent(s).

The invention discloses a stable recombinant human interferon ointment. The ointment is a semisolid water-soluble base ointment, wherein the formula oft the ointment contains a protecting agent, a stabilizer, and the like of the interferon; the ointment can be placed for over 2 years under the condition of 4-10 DEG C; the activity of the interferon is maintained between 80% and 150% of labeled amount, thereby being capable of satisfying the industrial and commercial requirements of medicaments.

The invention relates to a ketoconazole vaginal suppository as well as a preparation method and a detection method thereof. The suppository comprises a drug-containing base formed of ketoconazole and a base, a drug-containing mucous layer formed of ketoconazole and a mucous layer, and a swelling carrier. The oleaginous base and water soluble base are added, thereby ensuring that the whole body absorption and application risk of ketoconazole are reduced and the concentration and bioavailability of ketoconazole are effectively improved, so as to take full play of the efficacy of ketoconazole; an absorption promoting agent and chitosan are added, the absorption of a human body to ketoconazole is promoted; the solid disperse carrier can be used for improving the dissolution of ketoconazole, and further promoting absorption of the human body; the drug-containing mucous layer can be adsorbed on vaginal skin to promote skin absorption and can be used for further improving the bioavailability of ketoconazole. The ketoconazole vaginal suppository provided by the invention adopts six original advanced techniques, and has the beneficial effects of drug liquid outflow prevention, good human body absorption, high bioavailability, lasting curative effect, secondary infection prevention, and the like.

The invention relates to a gel paste preparation. The preparation comprises a water-soluble base, an emulsifier and a humectant, wherein a preparation method of the gel paste comprises the following steps of: adding the humectant of which the amount does not surpass 20 percent of the weight of a finished product into alginate of which the amount does not surpass 5 percent of the weight of the finished product and chitosan of which the amount does not surpass 3 percent of the weight of the finished product serving as main auxiliary materials; and adding the emulsifier of which the amount does not surpass 20 percent of the weight of the finished product into a mixed system to obtain the gel paste. The gel paste preparation prepared by the method has the advantages of simple formula, small dosage, little effect on medicaments and high safety.

This invention relates to a stable aqueous wax dispersion comprisingA) from 5 to 65% by weight of micronized wax, the wax comprising an amide wax, polyethylene wax, modified polyethylene wax, polyethylene / amide wax, polyethylene / polytetrafluroethylene (PTFE) wax, polypropylene wax, modified polypropylene wax, polyethylene / polypropylene wax, polytetrafluroethylene (PTFE) wax or copolymers thereof or any mixture thereof having a mean particle size of from 1 to 100 μm and an acid number of less then 10 mg of KOH / g of wax andB) 0.5 to 20% by weight of a thickening / dispersing agent, comprising of a alkali swellable acrylic polymers (ASE) or a hydrophobically modified alkali swellable emulsion (HASE) or a hydrophobically modified ethoxylated urethane (HEUR) or a polymer containing both a high molecular weight acrylic copolymer moiety and a hydrophobically modified ethoxylated urethane as a thickening / dispersing agent or mixtures thereofC) 0 to 5% by weight of a water soluble base as a neutralizing agentD) 0 to 5% by weight of a surface active / dispersant agentE) 0 to 40% by weight of a polymeric binder or polymeric bindersF) 0 to 5% by weight smectic clay thickening agent(s).

The invention relates to the technical field of a water transfer film and particularly relates to a water transfer film with concave and convex effects and a preparation method thereof. The water transfer film comprises a water-soluble base film layer, a concave pattern layer, a film removal protection layer and an ink pattern layer, and the layers are orderly pasted from top to bottom. The concave pattern layer comprises an aqueous coating. The aqueous coating comprises, by weight, 5% to 6% of matting powder, 30% to 35% of a film former, 1.5% to 2% of an aqueous wax emulsion, 2% to 3% of a water-based thickening aid, 8% to 10% of propylene glycol monoethyl ether, 1% to 1.5% of an aqueous defoamer, 6% to 8% of n-butanol and the balance of water. Through the water transfer film, the transferred patterns have concave-convex effects and through combination with the patterns, the realistic effect is produced.

The present invention provides a composition for inhibiting renal cancer cell growth and enhancing kidney function. This composition is constituted of water-soluble base material, plasticity-increasing base material, Antrodia camphorata extract, Ganoderma lucidum extract, and auxiliary enzyme. Differing from the conventional therapeutics treating the glomerulonephritis by administering high-dosage steroid for 1-4 months, the renal function of a patient suffering with serious kidney failure can be obviously enhanced after administering this composition of 7 mg / day / kg to the patient for 20 days. Moreover, because the cell biological experiments have proved that the of the present invention possess the functionality to inhibit renal cancer cell growth, this novel composition can indeed be used with chemotherapy drugs clinically, so as to solve the issue that the chemotherapy drugs cannot effectively inhibit the renal cancer cell growth.